[HTML][HTML] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-…

[HTML][HTML] Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation

K Rieger, O Marinets, T Fietz, S Körper… - Experimental …, 2005 - Elsevier
OBJECTIVE: Plasticity of hematopoietic stem cells (HSC) has gained major interest in stem
cell research. In order to investigate whether HSC may differentiate into mesenchymal stem …

[HTML][HTML] One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

S Körper, B Grüner, D Zickler… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Results of many randomized trials on COVID-19 convalescent plasma (CCP)
have been reported, but information on long-term outcome after CCP treatment is limited. …

[HTML][HTML] mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects

…, A Grempels, R Lotfi, A Janda, S Körper… - Vaccines, 2021 - mdpi.com
To identify the most efficient methods of immunological protection against SARS-CoV-2,
including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—…

Independent side-by-side validation and comparison of 4 serological platforms for SARS-CoV-2 antibody testing

…, VM Corman, T Schwarz, S Körper… - The Journal of …, 2021 - academic.oup.com
Highly sensitive and specific platforms for the detection of anti–severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) antibodies are becoming increasingly important for …

Altered increase in STAT1 expression and phosphorylation in severe COVID‐19

…, L Stefanski, AC Lino, S Körper… - European journal of …, 2022 - Wiley Online Library
The interferon pathway, a key antiviral defense mechanism, is being considered as a
therapeutic target in COVID‐19. Both, substitution of interferon and JAK/STAT inhibition to limit …

[HTML][HTML] Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data

…, E Veronesi, AB Ahmed, M Wiesneth, S Körper… - Cytotherapy, 2019 - Elsevier
Background Many data are available on expansion protocols for mesenchymal stromal cells
(MSCs) for both experimental settings and manufacturing for clinical trials. However, there is …

Characterization of the SARS-CoV-2 neutralization potential of COVID-19–convalescent donors

…, C Ludwig, T Schwarz, S Körper… - The Journal of …, 2021 - journals.aai.org
The current SARS-CoV-2 pandemic has triggered the development of various SARS-CoV-2
neutralization tests. A wild-type virus (using African green monkey VeroE6 cells), a …

[HTML][HTML] Donors for SARS-CoV-2 convalescent plasma for a controlled clinical trial: donor characteristics, content and time course of SARS-CoV-2 neutralizing …

S Körper, B Jahrsdörfer, VM Corman, J Pilch… - Transfusion Medicine …, 2021 - karger.com
Background: Convalescent plasma is one of the treatment options for COVID-19 which is
currently being investigated in many clinical trials. Understanding of donor and product …

[HTML][HTML] Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers

S Körper, M Wink, RHA Fink - Febs Letters, 1998 - Elsevier
The effects of the alkaloids ajmaline, lupanine, sparteine, serpentine, strychnine, and yohimbine
were studied with the loose patch clamp technique on sodium currents of isolated single …